NCT05034406

Brief Summary

Aim of this study is to examine the effects of subcutaneously applied local anesthetics at trocar site in combination with intraoperative intraperitoneal analgesia on duration and character of pain in pediatric patients undergoing laparoscopic varicocelectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 5, 2021

Completed
Last Updated

September 5, 2021

Status Verified

September 1, 2021

Enrollment Period

2.1 years

First QC Date

August 9, 2021

Last Update Submit

September 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain (as measured by Visual analogue scale)

    Visual analogue scale (VAS, 0-10 scale with 10 being the strongest pain) of pain assessed by a blinded investigator.

    6 hours after surgery

Secondary Outcomes (3)

  • Pain (as measured by Visual analogue scale)

    2 hours after surgery

  • Pain (as measured by Visual analogue scale)

    12 hours after surgery

  • Pain (as measured by Visual analogue scale)

    24 hours after surgery

Study Arms (3)

Lidocaine group

EXPERIMENTAL

A total amount of 6 mL of 2% lidocaine was injected at the three trocar insertion sites (2 mL at each insertion site) prior to incision and 10 mL of 2% lidocaine was injected at the end of procedure, under the direct visualization of laparoscope, below and around the defect of the peritoneum at the site of varicocele.

Drug: 2% Lidocaine

Levobupivacaine

EXPERIMENTAL

Total amount of 6 mL of 0.5% levobupivacaine was injected at the three trocar insertion sites (2 mL at each) prior to incision and 10 mL of 2% lidocaine was injected at the end of procedure, under the direct visualization of laparoscope, below and around the defect of the peritoneum at the site of varicocele.

Drug: 0.5% levobupivacaine

Control group

NO INTERVENTION

No local or peritoneal administration of any local anesthetic prior, during and after the surgical procedure

Interventions

6 mL of 2% lidocaine injected at the trocar insertion site.

Lidocaine group

6 mL of 0.5% levobupivacaine injected at the trocar insertion site.

Levobupivacaine

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • pediatric patients with varicocele who underwent laparoscopic varicocelectomy
  • pediatric patients whose parents or guardians gave informed consent

You may not qualify if:

  • patients who received open or microsurgical varicocelectomy
  • pediatric patients who underwent conversion to open procedure
  • pediatric patients with chronic, metabolic and endocrine diseases
  • pediatric patients with systemic infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Split

Split, Split-Dalmatia County, 21000, Croatia

Location

MeSH Terms

Conditions

VaricocelePain, Postoperative

Interventions

LidocaineLevobupivacaine

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesVascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesBupivacaine

Study Officials

  • Zenon Pogorelić, MD, PhD

    University of Split, School of Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor, surgery resident

Study Record Dates

First Submitted

August 9, 2021

First Posted

September 5, 2021

Study Start

May 1, 2019

Primary Completion

May 31, 2021

Study Completion

May 31, 2021

Last Updated

September 5, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations